Biohaven Pharmaceutical Holding Co Ltd logo

Biohaven Pharmaceutical Holding Co Ltd

$ 148.03 +0.02 (+0.01%) 03:43 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 10.58B
Enterprise V:
$ 10.79B
Volume:
155.24K
Avg Vol (2M):
731.74K
Also Trade In:
Volume:
155.24K
Market Cap $:
10.58B
PE Ratio:
At Loss
Avg Vol (2-Month):
731.74K
Enterprise Value $:
10.79B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Biohaven Pharmaceutical Holding Co Ltd
NAICS : 325412 SIC : 2834
C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, USA, 06510
Description
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Name Current Vs Industry Vs History
Cash-To-Debt 0.72
Equity-to-Asset -0.58
Debt-to-Equity -0.96
Debt-to-EBITDA -1.06
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.01
Distress
Grey
Safe
Beneish M-Score -0.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -22
3-Year EPS without NRI Growth Rate -28.6
3-Year FCF Growth Rate -35.8
Name Current Vs Industry Vs History
5-Day RSI 83.69
9-Day RSI 76.97
14-Day RSI 71.04
6-1 Month Momentum % 2.15
12-1 Month Momentum % 26.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.75
Quick Ratio 1.59
Cash Ratio 0.82
Days Inventory 246.61
Days Sales Outstanding 119.79
Days Payable 166.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.8
Name Current Vs Industry Vs History
Gross Margin % 85.63
Operating Margin % -74.44
Net Margin % -108.04
ROA % -79.9
ROIC % -223.85
ROC (Joel Greenblatt) % -5651.99
ROCE % -118.17

Financials (Next Earnings Date:2022-11-09 Est.)

BHVN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:BHVN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 859.684
EPS (TTM) ($) -14.82
Beta 1.35
Volatility % 76.69
14-Day RSI 71.04
14-Day ATR ($) 0.683301
20-Day SMA ($) 146.717
12-1 Month Momentum % 26.68
52-Week Range ($) 79.01 - 151.51
Shares Outstanding (Mil) 71.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biohaven Pharmaceutical Holding Co Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More